中/EN Contact/Message
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • Home
  • central pharmacy
  • Policies
  • Medical Institution
  • Franchise
  • Innovate
  • Recruit
  • News
  • 中/EN
  • Contact/Message
    • Innovate
    Your current position：
    Relyvrio
    Relyvrio
    departments：内科
    drug：口服溶液剂
    Active：sodium phenylbutyrate/taurursodiol
    indication：治疗肌萎缩性侧索硬化症（ALS）
    Licensor：Amylyx Pharmaceuticals
    Approved Country/Region：FDA
    Approval time：2022-09-29